series-a
Stage
1
Investors
About
We develop high-performance biologicals using microbiome technologies, data analysis and genome editing. Our products enhance crop yield in a sustainable way.
Explore Symbiomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.